-transparent.png){kind=logo}
When administered by intraperitoneal injection daily for 3, 7 or 14 days, pargyline (75 mg/kg) significantly reduced rat hepatic microsomal ethylmorphine N-demethylase activity and cytochrome P-450 content. Injection of a lower dose of pargyline (15 mg/kg) failed to alter significantly either ethylmorphine N-demethylase activity or cytochrome P-450 content. Studies performed in vitro reveal that pargyline is metabolized to at least three compounds by rat hepatic microsomes. Thin-layer chromatography and other analyses suggest that one metabolite is an N-demethylated form, norpargyline.
Related Publications
D M Valerino, and
E S Vesell, and
J T Stevens, and
S L Rudnick
June 1970,
Chemico-biological interactions,
D M Valerino, and
E S Vesell, and
J T Stevens, and
S L Rudnick
June 1985,
Biochemical pharmacology,
D M Valerino, and
E S Vesell, and
J T Stevens, and
S L Rudnick
January 1971,
Biochemical and biophysical research communications,
D M Valerino, and
E S Vesell, and
J T Stevens, and
S L Rudnick
January 1962,
Federation proceedings,
D M Valerino, and
E S Vesell, and
J T Stevens, and
S L Rudnick
April 1987,
Toxicology,
D M Valerino, and
E S Vesell, and
J T Stevens, and
S L Rudnick
July 1976,
Cancer research,
D M Valerino, and
E S Vesell, and
J T Stevens, and
S L Rudnick
January 1999,
European journal of drug metabolism and pharmacokinetics,
D M Valerino, and
E S Vesell, and
J T Stevens, and
S L Rudnick
March 1983,
Biochemical pharmacology,
D M Valerino, and
E S Vesell, and
J T Stevens, and
S L Rudnick
February 1981,
Toxicology letters,
D M Valerino, and
E S Vesell, and
J T Stevens, and
S L Rudnick
January 1995,
Indian journal of physiology and pharmacology,
